1,610,065 Shares of Vivmark Residential Common Shares of Beneficial Interest $VMRK Purchased by Bahl & Gaynor LLC

Posted by Brenda Bartman on Nov 11th, 2026

Bahl & Gaynor LLC bought a new position in shares of Vivmark Residential Common Shares of Beneficial Interest (NYSE:VMRK – Free Report) in the 3rd quarter, Holdings Channel.com reports. The institutional investor bought 1,610,065 shares of the company’s stock, valued at approximately $97,828,000.

Other institutional investors and hedge funds also recently modified their holdings of the company. Pensionfund Sabic acquired a new stake in Vivmark Residential Common Shares of Beneficial Interest in the third quarter worth $3,181,000. Perpetual Ltd acquired a new position in shares of Vivmark Residential Common Shares of Beneficial Interest in the 3rd quarter valued at $26,651,000. Red Spruce Capital LLC acquired a new position in shares of Vivmark Residential Common Shares of Beneficial Interest in the 3rd quarter valued at $1,367,000. LDR Capital Management LLC acquired a new position in shares of Vivmark Residential Common Shares of Beneficial Interest in the 3rd quarter valued at $1,703,000. Finally, Pensionfund PDN bought a new stake in shares of Vivmark Residential Common Shares of Beneficial Interest in the 3rd quarter valued at $6,617,000. 92.68% of the stock is owned by institutional investors.

Insider Buying and Selling at Vivmark Residential Common Shares of Beneficial Interest

In other Vivmark Residential Common Shares of Beneficial Interest news, EVP Edward M. Schulman sold 16,595 shares of the company’s stock in a transaction that occurred on Tuesday, August 18th. The stock was sold at an average price of $64.29, for a total transaction of $1,066,892.55. Following the completion of the transaction, the executive vice president owned 48,776 shares of the company’s stock, valued at $3,135,809.04. This represents a 25.39% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Susan Swanezy sold 15,700 shares of the firm’s stock in a transaction that occurred on Tuesday, August 18th. The stock was sold at an average price of $63.80, for a total transaction of $1,001,660.00. Following the transaction, the director directly owned 28,934 shares of the company’s stock, valued at $1,845,989.20. This represents a 35.17% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold 58,286 shares of company stock valued at $3,735,822 in the last 90 days. 1.20% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

Several analysts recently commented on the company. BMO Capital Markets dropped their price objective on Vivmark Residential Common Shares of Beneficial Interest from $75.00 to $74.00 and set a “market perform” rating on the stock in a research note on Monday, August 24th. Wells Fargo & Company reduced their target price on Vivmark Residential Common Shares of Beneficial Interest from $72.00 to $68.00 and set an “overweight” rating on the stock in a report on Monday, October 19th. JPMorgan Chase & Co. started coverage on Vivmark Residential Common Shares of Beneficial Interest in a research note on Monday, August 24th. They issued a “neutral” rating and a $73.00 target price for the company. Weiss Ratings assumed coverage on Vivmark Residential Common Shares of Beneficial Interest in a report on Wednesday, August 19th. They issued a “hold (c)” rating for the company. Finally, Evercore assumed coverage on Vivmark Residential Common Shares of Beneficial Interest in a report on Tuesday, August 18th. They issued an “in-line” rating and a $72.00 price target for the company. Five research analysts have rated the stock with a Buy rating and eleven have issued a Hold rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus target price of $71.42.

View Our Latest Research Report on VMRK

Vivmark Residential Common Shares of Beneficial Interest Stock Down 0.5%

Shares of NYSE:VMRK opened at $65.78 on Wednesday. Vivmark Residential Common Shares of Beneficial Interest has a 12 month low of $57.57 and a 12 month high of $71.50. The company has a current ratio of 0.35, a quick ratio of 0.19 and a debt-to-equity ratio of 0.08. The stock’s fifty day moving average is $62.62. The firm has a market capitalization of $24.66 billion, a price-to-earnings ratio of 220.47, a price-to-earnings-growth ratio of 3.82 and a beta of 0.72.

Vivmark Residential Common Shares of Beneficial Interest (NYSE:VMRK – Get Free Report) last released its quarterly earnings results on Wednesday, July 22nd. The company reported $0.30 earnings per share (EPS) for the quarter. Vivmark Residential Common Shares of Beneficial Interest had a negative return on equity of 0.80% and a negative net margin of 4.21%. The firm had revenue of $785.05 million for the quarter. Research analysts expect that Vivmark Residential Common Shares of Beneficial Interest will post 4.08 earnings per share for the current fiscal year.

Vivmark Residential Common Shares of Beneficial Interest Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, October 16th. Stockholders of record on Monday, October 5th were given a dividend of $0.7025 per share. This represents a $2.81 annualized dividend and a dividend yield of 4.3%. The ex-dividend date of this dividend was Monday, October 5th. Vivmark Residential Common Shares of Beneficial Interest’s dividend payout ratio is currently 1,040.74%.

About Vivmark Residential Common Shares of Beneficial Interest

(Free Report)

Equity Residential is committed to creating communities where people thrive. The Company, a member of the S&P 500, is focused on the acquisition, development and management of residential properties located in and around dynamic cities that attract high quality long-term renters. Equity Residential owns or has investments in 305 properties consisting of 78,568 apartment units, located in Boston, New York, Washington, D.C., Seattle, San Francisco, Southern California and Denver.